Stay Alert for Tendon Problems With Aromatase Inhibitors

April 2023

Health Canada is warning about the risk of tendon disorders with aromatase inhibitors (anastrozole, exemestane, letrozole).

Product monographs for these meds already caution about the risk of tendon sheath inflammation (tenosynovitis) of the hands.

Now the warning will be expanded to include the risk of tendonitis and tendon rupture...affecting upper and lower limbs.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Med Safety Stop Wrong-Patient Errors in Their Tracks
COVID-19 Continue to Identify Patients Who May Need a COVID-19 Booster
COVID-19 Help People Cope With Long COVID
Antibiotics Listen for Questions About Seizures With Cephalosporins
Menopause Be Familiar With Options to Manage Vaginal Menopausal Symptoms
Pain Management Expect More Buprenorphine Rxs for Chronic Pain
Med Safety Stay Alert for Tendon Problems With Aromatase Inhibitors
Cardiology Improve Safety With Heart Rhythm Meds
Cardiology Camzyos Will Be a New Med for a Genetic Heart Condition